Cargando…
Organerhalt: Entscheidungskriterien für Patienten mit T3-Larynxkarzinom
BACKGROUND: By today’s standard, the optimal treatment of every individual tumor patient is discussed and determined in an interdisciplinary tumor board. According to the new S3 guidelines, larger volume T3 laryngeal cancers which are no longer safely resectable with larynx-sparing surgery are ideal...
Autores principales: | Dyckhoff, Gerhard, Warta, Rolf, Herold-Mende, Christel, Plinkert, Peter K., Ramroth, Heribert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Medizin
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329161/ https://www.ncbi.nlm.nih.gov/pubmed/35575826 http://dx.doi.org/10.1007/s00106-022-01177-7 |
Ejemplares similares
-
Larynxorganerhalt bis zum T4‑Larynxkarzinom?
por: Dyckhoff, Gerhard, et al.
Publicado: (2022) -
Chemoradiotherapy but Not Radiotherapy Alone for Larynx Preservation in T3. Considerations from a German Observational Cohort Study
por: Dyckhoff, Gerhard, et al.
Publicado: (2021) -
Could Primary Chemoradiotherapy in T2 Glottic Cancers Yield Results Comparable to Primary Radiotherapy in T1? Considerations from 531 German Early Stage Patients
por: Dyckhoff, Gerhard, et al.
Publicado: (2021) -
An Observational Cohort Study on 194 Supraglottic Cancer Patients: Implications for Laser Surgery and Adjuvant Treatment
por: Dyckhoff, Gerhard, et al.
Publicado: (2021) -
Evaluation einer Basisschulung für Patienten mit rheumatoider Arthritis
por: Gerlich, C., et al.
Publicado: (2020)